Comorbidities and rheumatological diseases at the time of COVID-19. Response to: 'Rheumatic diseases in intensive care unit patients with COVID-19' by Moiseev et al

Ann Rheum Dis. 2021 Feb;80(2):e17. doi: 10.1136/annrheumdis-2020-217800. Epub 2020 May 20.
No abstract available

Keywords: antirheumatic agents; arthritis, rheumatoid; cardiovascular diseases.

Publication types

  • Letter
  • Comment

MeSH terms

  • COVID-19*
  • Humans
  • Hydroxychloroquine
  • Intensive Care Units
  • Rheumatic Diseases* / epidemiology
  • SARS-CoV-2

Substances

  • Hydroxychloroquine